HINDUNILVR Q2 2026 10:30 UTC Earnings Report

Page 1

23rd October, 2025 Stock Code BSE: 500696 NSE: HINDUNILVR ISIN: INE030A01027 Dear Sir / Madam, Sub: Outcome of the Board Meeting held on 23rd October, 2025 This is further to our letter dated 12th September, 2025, intimating the date of Board Meeting for consideration of Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30th September, 2025. Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘ SEBI Listing Regulations’), we would like to inform you that the Board at its meeting held today: 1. has approved the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30th September, 2025. We attach herewith a copy of the approved Unaudited Standalone and Consolidated Financial Results along with the Limited Review Reports of the Auditors. We are arranging to publish these results in the newspapers as per Regulation 47 of SEBI Listing Regulations. 2. declared interim dividend of Rs. 19 per equity share of face value of Re. 1/- each for the financial year ending 31st March, 2026 . The record date for the purpose of determining the entitlement of the shareholders for the interim dividend has been fixed as Friday, 7th November, 2025, and dividend will be paid to the shareholders on Thursday, 20 th November, 2025. The Board Meeting commenced at 09:30 A.M. (IST) and the discussion on the above items concluded at 10: 38 A.M. (IST). The Board Meeting is continuing for consideration of other agenda items. BSE Limited, Corporate Relationship Department, 2nd Floor, New Trading Wing, Rotunda Building, P.J. Towers, Dalal Street, Mumbai – 400 001 National Stock Exchange of India Ltd Exchange Plaza, 5th Floor, Plot No. C/1, G Block, Bandra – Kurla Complex, Bandra (E), Mumbai – 400 051 Hindustan Unilever Limited, Unilever House, B D Sawant Marg, Chakala, Andheri East, Mumbai 400 099 Tel: +91 (22) 50433000 I Web: www.hul.co .in I CIN: L 15140MH1933PLC002030

Page 2

Please take the above information on record. Thanking You. Yours faithfully, For Hindustan Unilever Limited Radhika Shah Company Secretary & Compliance Officer Membership No: A19308 Encl: as above Hindustan Unilever Limited, Unilever House, B D Sawant Marg, Chakala, Andheri East, Mumbai 400 099 Tel: +91 (22) 50433000 I Web: www.hul.co.in I CIN: L 15140MH1933PLC002030

Page 3

Sign in to continue

Your watchlist and earnings event details are available after you sign in.

Walker Chandiok &.Co LLP Walker Chandiok & Co LLP 16th Floor, Tower Ill, One International Center, S B Marg, Prabhadevi (W), Mumbai - 400013 Maharashtra, India T +91 22 6626 2699 F +91 22 6626 2601 Independent Auditor's Review Report on the Consolidated Unaudited Quarterly Financial Results and Year to Date Results of the Company pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) To the Board of Directors of Hindustan Unilever Limited 1. We have reviewed the accompanying statement of unaudited consolidated financial results ('the Statement') of Hindustan Unilever Limited ('the Holding Company') and its subsidiaries (the Holding Company and its subsidiaries together referred to as 'the Group'), and its joint venture, (refer Annexure 1 for the list of entities included in the Statement) for the quarter ended 30 September 2025 and the consolidated year to date results for the period 01 April 2025 to 30 September 2025, being submitted by the Holding Company pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) ('Listing Regulations'). 2. This Statement, which is the responsibility of the Holding Company's management and approved by the Holding Company's Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34, Interim Financial Reporting ('Ind AS 34'), prescribed under Section 133 of the Companies Act, 2013 ('the Act'), and other accounting principles generally accepted in India and is in compliance with the presentation and disclosure requirements of Regulation 33 of the Listing Regulations. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, Review of Interim Financial Information Performed by the Independent Auditor of the Entity, issued by the Institute of Chartered Accountants of India. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with the Standards on Auditing specified under Section 143(10) of the Act, and consequently, does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. We also performed procedures in accordance with the circular issued by the SEBI under Regulation 33 (8) of the Listing Regulations, to the extent applicable. Chartered Accountants Offices in Bengaluru, Chandigarh, Chennai, Gurugram, Hyderabad, Kodii, Kolkata, Mumbai, New Delhi, Noida and Puna Walker Chandiok & Co LLP is registered with limit ed liabilit y with identification number AAC-2085 and has its registered office at l-41 , Connaught Circus, Outer Circle, New Delhi, 110001, India

Page 4

Hindustan Unilever Limited Independent Auditor's Review Report on the Consolidated Unaudited Quarterly Financial Results and Year to Date Results of the Company pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) 4. Based on our review conducted and procedures performed as stated in paragraph 3 above and upon consideration of the review reports of the other auditors referred to in paragraph 5 below, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in Ind AS 34, prescribed under Section 133 of the Act, and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in accordance with the requirements of Regulation 33 of the Listing Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement. 5. We did not review the interim financial information of One (1) subsidiary i.e. Unilever Nepal Limited, included in the Statement, whose financial information reflects total assets of f 534 crores as at 30 September 2025, and total revenues off 123 crores and f 254 crores, total net profit after tax off 21 crores and f 50 crores, total comprehensive income of f 21 crores and f 50 crores, for the quarter and year-to-date period ended on 30 September 2025, respectively, and net cash inflows of f 5 crores for the period 01 April 2025 to 30 September 2025, as considered in the Statement. These interim financial information have been reviewed by other auditors whose review report has been furnished to us by the management, and our conclusion in so far as it relates to the amounts and disclosures included in respect of this subsidiary is based solely on the review reports of such other auditors and the procedures performed by us as stated in paragraph 3 above. Our conclusion is not modified in respect of this matter with respect to our reliance on the work done by and the report of the other auditor. 6. The Statement includes the Group's share of net loss of f 3 crores and f 4 crores, total comprehensive loss of f 3 crores and f 4 crores for the quarter and year-to-date period ended on 30 September 2025 respectively, in respect of One (1) joint venture, i.e. Nutritionalab Private Limited, based on their interim financial information, which have not been reviewed by their auditors, and have been furnished to us by the Holding Company's management. Our conclusion on the Statement, in so far as it relates to the amounts and disclosures included in respect of this joint venture, is based solely on such unreviewed interim financial information. According to the information and explanations given to us by the management, this interim financial information are not material to the Group. Our conclusion is not modified in respect of this matter with respect to our reliance on the financial information certified by the Management. For Walker Chandiok & Co LLP Chartered Accountants Firm Registration No: 001076N/N500013 Aasheesh Digitally signed by Aasheesh Arjun Singh ArJ'un s·1ngh Date:2025.10 .23 10:50:17 +05'30' Aasheesh Arjun Singh Partner Membership No. 210122 UDIN: 25210122BMONCU9475 Place: Mumbai Date: 23 October 2025 Chartered Accountants Offices in Bengaluru, Chandigarh, Chennai, Gurugram, Hyderabad, Kochi, Kolkata, Mumbai, New Delhi, Noida and Pune Walker Chandiok & Co LLP is registered with limited liabilit y with identification number AAC-2085 and has its regist ered offic e at L-41, Connaught Orcus, Outer Qrcle, New Delhi, 110001, India

Page 5

Page 6

~ U~e,.r Llm.uul CONSOLIDATED FINANCIAL RESULTS FOR THE QUARTER AND SIX MONTHS ENDED 30TH SEPTEMBER 2025 (Rs In Croresl Unaudited Results for Unaudited Results for Unaudited Results for Audited Results for the quarter ended the quarter ended Particulars six months ended the year ended 30th September 30th June 30th Se ,tember 31st March 2025 2024 2025 2025 2024 2025 Revenue from operations 16,034 15,703 16,296 Sale of products 32,330 31 ,200 62,175 27 26 27 Sale of services 54 52 113 180 197 191 Other operating revenue 371 381 833 147 219 201 Other income 348 476 1,017 16,388 16,145 16,715 TOTAL INCOME 33,103 32,109 64,138 EXPENSES 5,746 5,005 5,467 Cost of materials consumed 11 ,213 9,879 19,458 2,353 2,914 2,915 Purchases of stock-in-trade 5,268 5,642 11,273 (206) (210) (141) Changes in inventories of finished goods, work-in-progress and stock-in-trade (347) (267) (153) 750 822 726 Employee benefits expense 1,476 1,478 3,077 129 110 127 Finance costs 256 203 395 358 338 361 Depreciation and amortisation expense 719 667 1,355 other expenses 1,661 1,501 1,656 Advertising and promotion 3,317 3,182 6,199 2,208 2,101 2,173 others 4,381 4,182 8,416 12,999 12,581 13,284 TOTAL EXPENSES 26,283 24,966 50,020 3,389 3,564 3,431 Profit before exceptional items and tax and before share of equity.accounted investee 6,820 7,143 14,118 (3) (6) (1) Share of loss of equity-accounted investee, net of tax (4) (8) (8) 3,386 3,558 3,430 Profit before exceptional items and tax 6,816 7,135 14,110 184 (16) (127) Exceptional items (net credit I (charge)] 57 (64) 305 3,570 3,542 3,303 Profit before tax 6,873 7,071 14,415 Tax expenses (884) (940) (494) Current tax (1,378) (1,793) (3,620) 8 (7) (41) Deferred tax credit I (charge) (33) (71) (124) 2,694 2,595 2,768 PROFIT FOR THE PERIOD I YEAR (A) 5,462 5,207 10,671 OTHER COMPREHENSIVE INCOME Items that will not be reclassified to profit or loss Remeasl.rements of the net defined benefit plans (22) Tax on above 5 Items that will be reclassifted to profit or loss 1 1 Fair value of debt instruments through other comprehensive income 1 (0) (0) (0) 0 Tax on above (0) 0 0 3 (7) (22) Fair value of cash flow hedges through other comprehensive income (19) (8) (2) (0) 2 (0) Tax on above (0) 2 0 0 0 Exchange differences on translation of financial statements of foreign operations 0 Tax on above 4 (4) (22) OTHER COMPREHENSIVE INCOME FOR THE PERIOD I YEAR (B) (18) (6) (19) 2,698 2,591 2,746 TOTAL COMPREHENSIVE INCOME FOR THE PERIOD/ YEAR (A+B) 5,444 5,201 10,652 Net Profit attributable to 2,685 2,591 2,756 a) Ovvners of the Holding Company 5,441 5,201 10,649 9 4 12 b) Non-controlling interest 21 6 22 Other comprehensive income attributable to 4 (4) (22) a) Owners of the Holding Company (18) (6) (19) (0) 0 b) Non-controlling interest 0 0 Total comprehensive income attributable to 2,689 2,587 2,734 a) Ovvners of the Holding Company 5,423 5,195 10,630 9 4 12 b) Non-controlling interest 21 6 22 235 235 235 Paid up Equity Share Capital (Face value of Re. 1 per share) 235 235 235 Other Equity 49,167 Eamings per equity share (Face value of Re. 1 each) 11.43 11.03 11.73 Basic Qn Rs.) 23.16 22.14 45.32 11.43 11.03 11.73 Dluted (il Rs.) 23.16 22.14 45.32

Page 7

CONSOLIDATED SEGMENT WISE REVENUE RESULTS ASSETS AND LIABILITIES (Rs In Crores) Unaudited Results for Unaudited Results for Unaudited Results for Audited Results for the quarter ended the quarter ended Particulars six months ended the year ended 30th SeDtember 30th June 30th Seotember 31st March 2025 2024 2025 2025 2024 2025 Segment Revenue (Sales and Other operating revenue) 5,664 5,731 5,777 - Home Care 11 ,441 11,404 22,958 3,732 3,421 3,631 - Beauty & Wellbeing 7,363 6,702 13,523 2,425 2,411 2,540 - Personal Care 4,965 4,797 9,166 3,869 3,803 4,016 - Foods 7,885 7,653 15,294 551 560 550 - Others (includes EXJ>orts) 1101 1 077 2180 16241 15 926 16514 Total Seament Revenue 32 755 31 633 63121 Segment Results 1,083 1,114 1,129 - Home Care 2,212 2,250 4,429 1,061 1,123 999 - Beauty & Wellbeing 2,060 2,124 4,188 492 407 475 - Personal Care 967 832 1,631 629 690 652 - Foods 1,281 1,426 2,808 106 121 102 - Others (includes EXJ>orts) 208 238 440 3,371 3,455 3,357 Total Segment Results 6,728 6,870 13,496 (3) (6) (1) Less: Share of loss of equity-accounted investee, net of tax (4) (8) (8) Unallocable items: 147 219 201 Other Income 348 476 1,017 (129) (110) (127) Finance Costs (256) (203) (395) 164 (16) (127) Exceptional items lnet credit/ (charQe)l 57 (64) 305 3 570 3542 3 303 Profit Before Tax 6 873 7071 14415 Segment Assets 6,117 5,543 5,746 - Home Care 6,117 5,543 5,573 8,423 4,486 8,150 - Beauty & Wellbeing 8,423 4,486 4,391 3,641 3,853 3,870 - Personal Care 3,641 3,853 3,692 51,706 50,939 51,320 - Foods 51,706 50,939 51,571 1,174 1,086 1,208 - Others (includes Exports) 1,174 1,086 1,122 10773 14 858 14 800 - Unallocable coroorate assets 10 773 14 858 13 531 82 034 80765 85094 Total Assets 82034 80 765 79 880 Segment Liabilities 5,124 4,955 5,232 - Home Care 5,124 4,955 5,257 4,813 4,155 4,588 - Beauty & Wellbeing 4,813 4,155 4,252 2,739 2,960 2,926 - Personal Care 2,739 2,960 2,691 3,834 3,806 3,772 - Foods 3,834 3,806 3,730 552 488 623 - Others (includes Exports) 552 488 473 15 810 13414 21489 - Unallocable coroorate liabilities 15 810 13414 13 868 32 872 29778 38630 Total Liabilities 32 872 29 778 30 271 Segment Revenue, Results, Assets and Liabilities represent amounts identifiable to each of the segments. Other Income mainly includes interest income and income from current investments (net). Segment Assets and Segment Liabilities are as at 30th September 2025, 30th June 2025, 31st March 2025 and 30th September 2024. Unallocable corporate assets less Unallocable corporate liabilities mainly represent investment of surplus funds, cash and bank balances and tax assets and liabilities. Registered Office : Unilever House, B.D. Sawant Marg, Chakala, Andheri East, Mumbai 400 099. CIN : L15140MH1933PLC002030 , Tel : +91 (22) 5043 3000. Email: levercare.shareholder@unilever.com

Page 8

CONSOLIDATED BALANCE SHEET AS AT 30TH SEPTEMBER. 2025 (Rs in Crores) Unaudited Audited Statement of Assets and Liabilities Asal Asal 30th September, 2025 31st March, 2025 A ASSETS 1 Non-<:urrent assets Property , plant and equipment 8,881 8,625 Capital work-in-progress 1,022 1,009 Goodwill 18,098 17,466 Other intangible assets 31,147 28,244 Investments accounted for using the equity method 53 57 Financial assets - Investments 101 2 - Loans 97 87 - Other financial assets 1,042 763 Deferred tax assets 19 17 Non-current tax assets (net) 1,131 1,199 Other non-current assets 346 360 Total - Non-current assets 61,937 57,829 2 Current assets Inventories 4,488 4,415 Financial assets - Investments 3,804 3,751 - Trade receivables 4,440 3,819 - Cash and cash equivalents 2,341 6,071 - Bank balances other than cash and cash equivalents mentioned above 2,101 1,483 - Loans 48 46 - Other financial assets 1,723 1,488 Current tax assets (net) 4 - Other current assets 1,127 955 20,076 22,028 Assets held for sale 21 23 Total - Current assets 20,097 22,051 TOTAL -ASSETS 82,034 79,880 B EQUITY AND LIABILITIES 1 EQUITY Equity share capital 235 235 Other equity 48,481 49,167 Non-controlling interests 446 207 Total - Equity 49,162 49,609 2 LIABILITIES Non-<:urrent llabllltles Financial liabilities - Lease liabilities 1,363 1,243 - Other financial liabilities 1,129 680 Provisions 1,406 1,528 Deferred tax liabilities 7,440 6,685 Non-current tax liabilrties (net) 3,106 3,598 Total - Non-<:urrent liabilities 14,444 13,734 Current liabilities Financial liabilities - Borrowings 14 1 - Lease liabilities 398 404 - Trade payables total outstanding dues of micro enterprises and small enterprises 472 263 total outstanding dues of creditors other than micro enterprises and small enterprises 11 ,709 11 ,052 - Other financial liabilities 1,378 1,280 Other current liabilities 681 959 Provisions 907 675 Current tax liabilities (net) 2,869 1,903 Total - Current llabllltles 18,428 16,537 TOTAL - EQUITY AND LIABILITIES 82,034 79,880

Page 9

UNAUDITED CONSOLIDATED STATEMENT OF CASH FLOWS FOR THE SIX MONTHS ENDED 30TH SEPTEMBER, 2025 (Rs in Crores) Six Months ended Six Months ended 30th September, 2025 30th September, 2024 A CASH FLOWS FROM OPERATING ACTIVITIES : Profit before tax 6,873 7,071 Adjustments for: Depreciation and amortisation expenses 727 667 Loss on sale of property, plant and equipment 19 2 Interest income (218) (339) Other non operating income - Fair value gain on investments (110) (138) Interest expense 256 203 Payment from Retirement Benefit Scheme Reserve (0) - Share of loss of joint venture 4 8 Equity settled share based payment 15 - Reversal of indemnification asset on expiry of underlying income tax provision 34 - Inventory written off (net) 139 103 Bad debts/ assets (write back) / written off net of provision (5) 40 Mark-to-market (gain)/ loss on derivative financial instruments (15) 7 Cash Generated from operations before working capital changes 7,719 7,624 Adjustments for: (Increase)/ decrease in Non-Current assets 9 43 (Increase)/ decrease in Current Assets (935) (1 ,260) (Increase)/ decrease in Inventories (97) (364) Increase/ (decrease) in Non-Current Liabilities (164) (19) Increase/ (decrease) in Current Liabilities 573 1,030 Cash flows generated from operations 7,105 7,054 Taxes paid (net of refunds) (838) (397) Net cash flows generated from operating activities - [A] 6,267 6,657 B CASH FLOWS FROM INVESTING ACTIVITIES : Purchase of property, plant and equipment (617) (520) Sale proceeds of property, plant and equipment 10 7 Purchase of intangible assets (42) (7) Purchase consideration towards business combination (2,661) - Purchase of non-current investments (100) - Purchase of current investments (9,522) (12,171) Redemption proceeds of current investments 9,579 12,577 Loans given to others (net of repayment) - 0 Investment in term deposits (having original maturity of more than 3 months) (1 ,998) (1 ,641) Proceeds from redemption/ maturity of term deposits (having original maturity of more than 3 months) 1,090 5,075 Interest received 230 454 Net cash flows generated (used in) / from investing activities - [Bl (4,031) 3,774 C CASH FLOWS FROM FINANCING ACTIVITIES : Dividends paid (5,639) (5,639) Proceeds from current borrowings - 1 Repayment of current borrowings (46) - Principal payment of lease liabilities (237) (239) Interest paid on lease liabilities (68) (64) Interest paid on borrowings (2) (2) Net cash flows used in financing activities - [CJ (5,992) (5,943) Net Increase in cash and cash equivalents - [A+B+C] (3,756) 4,488 Add: Cash and cash equivalents at the beginning of the period 6,070 812 Add: Cash acquired under Business Combination 13 - Cash and cash equivalents at the end of the period 2,327 5,300 Components of cash and cash equivalents : Cash and cash equivalents as per Consolidated Balance Sheet 2,341 5,313 Less: Bank overdraft (14) (13) Cash and cash equivalents for Consolidated Statement of Cash Flows 2,327 5,300 Note: The above Consolidated Statement of Cash Flows has been prepared under the 'Indirect Method' as set out in Ind AS 7, 'Statement of Cash Flows'.

Page 10

Notes to consolidated financial results: 1. Total sales at Rs. 16,061 crores grew by 2% during the quarter. 2. Earnings before interest, tax, depreciation and amortization (EBITDA] for the quarter was Rs. 3,729 crores (SQ 24: Rs. 3,793 crores]. EBITDA margin at 23.2% declined by 90 bps vs SQ 24. 3. Profit after tax before exceptional items for the quarter at Rs. 2,482 crores (SQ 24: Rs. 2,594 crores] declined by 4%. 4. Exceptional items in SQ 25 include one-off positive impact pursuant to resolution of prior years· tax matters between UK and Indian tax authorities of Rs. 273 crores (SQ 24: Nill. restructuring expenses of Rs. 51 crores (SQ 24: Rs. 16 crores] and acquisition and disposal related costs of Rs. 38 crores (SQ 24: Nill. 5. Profit After Tax for the quarter at Rs. 2,694 crores (SQ 24: Rs. 2,595 crores] grew by 4%. 6. The shareholders of Hindustan Unilever Limited ('HUL'], at their meeting convened by the Honourable National Company Law Tribunal ("NCL T'] on 12th August 2025, approved the Scheme of Arrangement between HUL, Kwality Wall's (India] Limited ("KWIL'] and their respective shareholders to demerge HUL's ice cream business into KWIL. The scheme is subject to necessary statutory and regulatory approvals, including from the Honourable NCL T under Sections 230 and 232 of the Companies Act, 2013. This has no impact on the financial results for the period ended and as at 30th September 2025. 7. The Board of Directors declared an interim dividend of Rs. 19/- per equity share of face value of Re.1/- each for the financial year ending 31st March 2026. The record date for the purpose of determining the entitlement for payment of interim dividend is fixed as 7th November 2025. 8. The above results have been reviewed by the Audit Committee at its meeting held on 23rd October 2025 and approved by the Board of Directors at their meeting held on 23rd October 2025. 9. The statutory auditors have issued an unmodified report on the above results . 10. The text of the above statement was approved by the Board of Directors at their meeting held on 23rd October 2025. For more details on Results, visit Investor Relations section of our website at http://www .hul.co.in and Financial Results under Corporates section of www.nseindia.com and www.bseindia.com . Place: Mumbai Date: 23rd October 2025 By order of the Board of Directors P . Digitally signed by nya Priya Sukumar Nair Sukumar Nair Date: 2025.10.23 10:39:44 +05'30 ' Priya Nair Managing Director and Chief Executive Officer [DIN: 07119070]

Page 11

Walker Chandiok &.Co LLP Walker Chandiok & Co LLP 16th Floor, Tower Ill , One International Center, S B Marg, Prabhadevi (W), Mumbai - 400013 Maharashtra, India T +91 22 6626 2699 F +91 22 6626 2601 Independent Auditor's Review Report on the Standalone Unaudited Quarterly Financial Results and Year to Date Results of the Company pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) To the Board of Directors of Hindustan Unilever Limited 1. We have reviewed the accompanying statement of standalone unaudited financial results ('the Statement') of Hindustan Unilever Limited ('the Company') for the quarter ended 30 September 2025 and the year to date results for the period 01 April 2025 to 30 September 2025, being submitted by the Company pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) ('Listing Regulations'). 2. The Statement, which is the responsibility of the Company's management and approved by the Company's Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34, Interim Financial Reporting ('Ind AS 34'), prescribed under Section 133 of the Companies Act, 2013 ('the Act'), and other accounting principles generally accepted in India and is in compliance with the presentation and disclosure requirements of Regulation 33 of the Listing Regulations. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, Review of Interim Financial Information Performed by the Independent Auditor of the Entity, issued by the Institute of Chartered Accountants of India. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with the Standards on Auditing specified under Section 143(10) of the Act, and consequently, does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. Chartered Accountants Offices in Bengaluru, Chandigarh, Chennai, Gurugram, Hyderabad, Kodii, Kolkata, Mumbai, New Delhi, Noida and Puna Walker Chandiok & Co LLP is registered with limit ed liabilit y with identification number AAC-2085 and has its registered office at l-41 , Connaught Circus, Outer Circle, New Delhi, 110001, India

Page 13

(Rs in Crores) 30th June 2025 2024 2025 2025 2024 2025 Revenue from operations 15,418 15,319 15,747 Sale of products 31,165 30,485 60,680 167 189 184 Other operating revenue 351 362 789 228 309 247 Other income 475 566 1,177 15,813 15,817 16,178 TOTAL INCOME 31,991 31,413 62,646 EXPENSES 5,211 4,598 4,962 Cost of materials consumed 10,173 9,076 17,698 2,710 3,195 3,281 Purchases of stock-in-trade 5,991 6,213 12,584 (188) (200) (154) (342) (248) (106) 677 765 657 Employee benefits expense 1,334 1,367 2,840 111 99 110 Finance costs 221 184 364 324 305 324 Depreciation and amortisation expense 648 603 1,224 Other expenses 1,527 1,464 1,556 Advertising and promotion 3,083 3,108 6,028 2,085 2,039 2,071 Others 4,156 4,078 8,136 12,457 12,265 12,807 TOTAL EXPENSES 25,264 24,381 48,768 3,356 3,552 3,371 6,727 7,032 13,878 184 (16) (127) Exceptional items [net credit/ (charge)] 57 (64) 422 3,540 3,536 3,244 Profit before tax 6,784 6,968 14,300 Tax expenses (857) (912) (472) Current tax (1,329) (1,740) (3,525) 7 (12) (40) Deferred tax credit / (charge) (33) (78) (131) 2,690 2,612 2,732 PROFIT FOR THE PERIOD / YEAR (A) 5,422 5,150 10,644 OTHER COMPREHENSIVE INCOME Items that will not be reclassified to profit or loss - - - Remeasurements of the net defined benefit plans - - (22) - - - Tax on above - - 5 Items that will be reclassified to profit or loss 1 1 - Fair value of debt instruments through other comprehensive income 1 (0) (0) (0) 0 - Tax on above (0) 0 0 3 (7) (22) Fair value of cash flow hedges through other comprehensive income (19) (8) (2) (0) 2 (0) Tax on above (0) 2 0 4 (4) (22) OTHER COMPREHENSIVE INCOME FOR THE PERIOD / YEAR (B) (18) (6) (19) 2,694 2,608 2,710 TOTAL COMPREHENSIVE INCOME FOR THE PERIOD / YEAR (A+B) 5,404 5,144 10,625 235 235 235 Paid up Equity Share Capital (Face value Re. 1 per share) 235 235 235 Other Equity 48,918 11.45 11.12 11.63 Basic (in Rs.) 23.08 21.92 45.30 11.45 11.12 11.63 Diluted (in Rs.) 23.08 21.92 45.30 30th September Changes in inventories of finished goods, work-in-progress and stock-in-trade Profit before exceptional items and tax Earnings per equity share (Face value of Re. 1 each) STANDALONE FINANCIAL RESULTS FOR THE QUARTER AND SIX MONTHS ENDED 30TH SEPTEMBER, 2025 Unaudited Results for Unaudited Results for the quarter ended Unaudited Results for Audited Results for the year ended 31st March the quarter ended Particulars six months ended 30th September # ~ U....Rwev- ~

Page 14

(Rs in Crores) Unaudited Results for Audited Results for the quarter ended the year ended 30th June 31st March 2025 2024 2025 2025 2024 2025 Segment Revenue (Sales and Other operating revenue) 5,667 5,737 5,783 - Home Care 11,450 11,412 22,972 3,389 3,323 3,349 - Beauty & Wellbeing 6,738 6,522 13,073 2,426 2,412 2,541 - Personal Care 4,967 4,798 9,168 3,869 3,803 4,016 - Foods 7,885 7,653 15,294 234 233 242 - Others (includes Exports) 476 462 962 15,585 15,508 15,931 Total Segment Revenue 31,516 30,847 61,469 1,050 1,087 1,093 - Home Care 2,143 2,196 4,306 1,031 1,121 977 - Beauty & Wellbeing 2,008 2,127 4,176 487 401 470 - Personal Care 957 819 1,606 629 690 652 - Foods 1,281 1,426 2,808 42 43 42 - Others (includes Exports) 84 82 169 3,239 3,342 3,234 Total Segment Results 6,473 6,650 13,065 Unallocable items: 228 309 247 Other Income 475 566 1,177 (111) (99) (110) Finance Costs (221) (184) (364) 184 (16) (127) Exceptional items [net credit / (charge)] 57 (64) 422 3,540 3,536 3,244 Profit Before Tax 6,784 6,968 14,300 Segment Assets 5,668 5,104 5,279 - Home Care 5,668 5,104 5,112 4,074 3,906 3,834 - Beauty & Wellbeing 4,074 3,906 3,771 3,476 3,478 3,510 - Personal Care 3,476 3,478 3,316 51,705 50,939 51,320 - Foods 51,705 50,939 51,571 418 271 462 - Others (includes Exports) 418 271 307 14,135 15,590 18,102 - Unallocable corporate assets 14,135 15,590 14,236 79,476 79,288 82,507 Total Assets 79,476 79,288 78,313 Segment Liabilities 5,023 4,860 5,138 - Home Care 5,023 4,860 5,176 4,504 4,008 4,306 - Beauty & Wellbeing 4,504 4,008 4,069 2,727 2,965 2,907 - Personal Care 2,727 2,965 2,666 3,834 3,806 3,772 - Foods 3,834 3,806 3,730 208 163 256 - Others (includes Exports) 208 163 168 14,230 13,007 19,873 - Unallocable corporate liabilities 14,230 13,007 13,351 30,526 28,809 36,252 Total Liabilities 30,526 28,809 29,160 Notes: STANDALONE SEGMENT WISE REVENUE, RESULTS, ASSETS AND LIABILITIES Unaudited Results for the Particulars Unaudited Results for quarter ended six months ended 30th September 30th September Segment Results Segment Revenue, Results, Assets and Liabilities represent amounts identifiable to each of the segments. Other Income mainly includes interest income, dividend income and income from current investments (net). Segment Assets and Segment Liabilities are as at 30th September 2025, 30th June 2025, 31st March 2025 and 30th September 2024.Unallocable corporate assets less Unallocable corporate liabilities mainly represent investment of surplus funds, cash and bank balances and tax assets and liabilities. Registered Office : Unilever House, B.D. Sawant Marg, Chakala, Andheri East, Mumbai 400 099. CIN: L15140MH1933PLC002030. Tel : +91 (22) 5043 3000. Email: levercare.shareholder@unilever.com # ~ U.....Rww ~

Page 16

(Rs in Crores) Six months ended 30th September, 2025 Six months ended 30th September, 2024 A CASH FLOWS FROM OPERATING ACTIVITIES: Profit before tax 6,784 6,968 Adjustments for: Depreciation and amortisation expenses 656 603 Loss on sale of property, plant and equipment 18 2 Interest income (215) (342) Dividend income (140) (91) Other non operating income - Fair value gain on investments (104) (133) Interest expense 221 184 Equity settled share based payment 15 - Reversal of indemnification asset on expiry of underlying income tax provision 34 - Inventory written off (net) 139 93 Bad debts / assets (write back) / written off net of provision (3) 13 Mark-to-market (gain) / loss on derivative financial instruments (19) 5 Cash generated from operations before working capital changes 7,386 7,302 Adjustments for: (Increase)/decrease in Non-Current Assets 10 42 (Increase)/decrease in Current Assets (1,020) (1,232) (Increase)/decrease in Inventories (98) (325) Increase/(decrease) in Non-Current Liabilities (117) (16) Increase/(decrease) in Current Liabilities 514 1,060 Cash flows generated from operations 6,675 6,831 Taxes paid (net of refunds) (780) (351) Net cash flows generated from operating activities - [A] 5,895 6,480 B CASH FLOWS FROM INVESTING ACTIVITIES: Purchase of property, plant and equipment (575) (459) Sale proceeds of property, plant and equipment 10 7 Purchase of Intangible assets (42) (7) Purchase consideration towards business combination (2,706) - Purchase of non-current investments (100) - Purchase of current investments (8,195) (11,323) Redemption proceeds of current investments 8,219 11,776 Loans given to subsidiaries (105) (226) Loans repaid by subsidiaries 143 196 Loans given to others (net of repayment) - 0 Investment in term deposits (having original maturity of more than 3 months) (1,903) (1,579) Proceeds from redemption / maturity of term deposits (having original maturity of more than 3 months) 1,090 5,059 Interest received 227 457 Dividend received from subsidiaries 140 91 Net cash flows generated (used in) / from investing activities - [B] (3,797) 3,992 C CASH FLOWS FROM FINANCING ACTIVITIES: Dividends paid (5,639) (5,639) Principal payment of lease liabilities (218) (221) Interest paid on lease liabilities (62) (59) Net cash flows used in financing activities - [C] (5,919) (5,919) Net increase in cash and cash equivalents - [A+B+C] (3,821) 4,553 Add: Cash and cash equivalents at the beginning of the period 5,947 609 Cash and cash equivalents at the end of the period 2,126 5,162 UNAUDITED STANDALONE STATEMENT OF CASH FLOWS FOR THE SIX MONTHS ENDED 30th SEPTEMBER, 2025 Note: # The above Standalone Statement of Cash Flows has been prepared under the 'Indirect Method' as set out in Ind AS 7, 'Statement of Cash Flows'.

Page 17

Notes to standalone financial results: 1. Total sales at Rs. 15,418 crores grew by 1 % during the quarter. 2. Earnings before interest, tax, depreciation and amortization (EBITDA] for the quarter was Rs. 3,563 crores (SQ 24: Rs. 3,647 crores]. EBITDA margin at 23.1 % declined by 70 bps vs SQ 24. 3. Profit after tax before exceptional items for the quarter at Rs. 2,478 crores (SQ 24: Rs. 2,611 crores] declined by 5%. 4. Exceptional items in SQ 25 include one-off positive impact pursuant to resolution of prior years· tax matters between UK and Indian tax authorities of Rs. 273 crores (SQ 24: Nill, restructuring expenses of Rs. 51 crores (SQ 24: Rs. 16 crores] and acquisition and disposal related costs of Rs. 38 crores (SQ 24: Nill. 5. Profit After Tax for the quarter at Rs. 2,690 crores (SQ 24: Rs. 2,612 crores] grew by 3%. 6. The shareholders of Hindustan Unilever Limited ('HUL'], at their meeting convened by the Honourable National Company Law Tribunal ("NCL Tl on 12th August 2025, approved the Scheme of Arrangement between HUL, Kwality Wall's (India] Limited ("KWIL'] and their respective shareholders to demerge HUL's ice cream business into KWIL. The scheme is subject to necessary statutory and regulatory approvals, including from the Honourable NCL T under Sections 230 and 232 of the Companies Act, 2013. This has no impact on the financial results for the period ended and as at 30th September 2025. 7. The Board of Directors declared an interim dividend of Rs. 19/- per equity share of face value of Re.1/- each for the financial year ending 31st March 2026. The record date for the purpose of determining the entitlement for payment of interim dividend is fixed as 7th November 2025. 8. The above results have been reviewed by the Audit Committee at its meeting held on 23rd October 2025 and approved by the Board of Directors at their meeting held on 23rd October 2025. 9. The statutory auditors have issued an unmodified report on the above results . 10. The text of the above statement was approved by the Board of Directors at their meeting held on 23rd October 2025. For more details on Results, visit Investor Relations section of our website at http://www .hul.co.in and Financial Results under Corporates section of www.nseindia.com and www.bseindia.com . Place: Mumbai Date: 23rd October 2025 By order of the Board of Directors P • Digitally signed by Priya nya Sukumar Nair Sukumar Nair ~~~~~;~2s.10.2310,39,09 Priya Nair Managing Director and Chief Executive Officer [DIN: 07119070]

Page 1

Page 2

Page 3

Sign in to continue

Page 4

Page 5

Page 6

Page 7

Page 8

Page 9

Page 10

Page 11

Page 12

Page 13

Page 14

Page 15

Page 16

Page 17

Interim report

Page 1

Page 2

Page 3

Sign in to continue

Page 4

Page 5

Page 6

Page 7

Page 8

Page 9

Page 10

Page 11

Page 12

Page 13

Page 14

Page 15

Page 16

Page 17